Sort
23,748 grants matching “melanoma”
Core 2: RXR Rexinoid Design and Synthesis
$201,786Venkatram Reddy Atigadda · University Of Alabama At Birmingham · P01 · FY2020 · CA
Molecular Risk Assessment in Hereditary Melanoma
$201,771Hensin Tsao · Massachusetts General Hospital · K24 · FY2012 · CA
Molecular Risk Assessment in Hereditary Melanoma
$201,771Hensin Tsao · Massachusetts General Hospital · K24 · FY2011 · CA
Molecular Risk Assessment in Hereditary Melanoma
$201,771Hensin Tsao · Massachusetts General Hospital · K24 · FY2014 · CA
Molecular Risk Assessment in Hereditary Melanoma
$201,771Hensin Tsao · Massachusetts General Hospital · K24 · FY2013 · CA
Exploiting the Unique T Cell Response to CMV for a Cancer Vaccine
$201,725Ann B Hill · Oregon Health & Science University · R21 · FY2009 · CA
Targeted nanotechnology for the pancreatic tumor immune microenvironment
$201,715Martin G Pomper · Ut Southwestern Medical Center · P41 · FY2025 · EB
Regulation of Oncogene-Induced Senescence by Wnt-Signaling
$201,690Peter D. Adams · University Of Glasgow · R01 · FY2009 · CA
TRAINING IN IMMUNODERMATOLOGY
$201,633University Of Colorado Denver · T32 · FY2002 · AR
Sun protection Internet-based program for kidney transplant recipients
$201,623June K Robinson · Northwestern University At Chicago · R21 · FY2013 · CA
Discrete Sensor Devices for Determining Cancer Targets
$201,536Michael J Cima · Massachusetts Institute Of Technology · U54 · FY2010 · CA
TUMOR-TARGETING WITH NEW BORONATED PORPHYRINS
$201,520Maria Da Graca Henriques Vicente · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2010 · CA
Selective inhibition of Notch1 and ERBB3 by novel neutralizing antibodies to treat melanoma
$201,459Barbara Bedogni · University Of Miami School Of Medicine · R21 · FY2017 · CA
Multiple Antigen-Engineered DC Immunization and IFNalpha-2b Boost for Metastatic Melanoma
$201,435Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P50 · FY2015 · CA
PROTEIN KINASE C SIGNALING IN APOPTOSIS AND SKIN CANCER
$201,351Loyola University Chicago · R01 · FY2000 · CA
Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients
$201,286Michael H. A. Roehrl · Sloan-Kettering Inst Can Research · U01 · FY2022 · CA
Extracellular vesicle-associated MAVS and IFNẠin Dermatomyositis
$201,250Ming-Lin Liu · University Of Pennsylvania · R21 · FY2020 · AI
TCR TRANSDUCED CD4 T CELLS FOR ADOPTIVE IMMUNOTHERAPY
$201,200Michael I Nishimura · Loyola University Chicago · P01 · FY2014 · CA
MicroRNA and protein profiling in melanocytes exposed to solar UVR in situ
$201,198Mlnikki L Harter · Case Western Reserve University · R21 · FY2014 · ES
Administration, Evaluation, and Planning
$201,132Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA
Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients
$201,131Michael H. A. Roehrl · Beth Israel Deaconess Medical Center · U01 · FY2023 · CA
SOUTHWEST ONCOLOGY GROUP
$201,061University Of Southern California · U10 · FY2003 · CA
High dimensional digital pathology to investigate the tumor micro environment and its impact on response to therapy
$201,041Zoltan Maliga · Harvard Medical School · R50 · FY2024 · CA
High dimensional digital pathology to investigate the tumor micro environment and its impact on response to therapy
$201,041Zoltan Maliga · Harvard Medical School · R50 · FY2023 · CA
CORE--Biostatistics Core D: U. of PA consortium
$201,021Phyllis A Gimotty · Wistar Institute · P01 · FY2008 · CA